Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice

Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice

• Text
• PDF

Abstract

To elucidate the role of cardiac myosin-binding protein-C (MyBP-C) in myocardial structure and function, we have produced mice expressing altered forms of this sarcomere protein. The engineered mutations encode truncated forms of MyBP-C in which the cardiac myosin heavy chain-binding and titin-binding domain has been replaced with novel amino acid residues. Analogous heterozygous defects in humans cause hypertrophic cardiomyopathy. Mice that are homozygous for the mutated MyBP-C alleles express less than 10% of truncated protein in M-bands of otherwise normal sarcomeres. Homozygous mice bearing mutated MyBP-C alleles are viable but exhibit neonatal onset of a progressive dilated cardiomyopathy with prominent histopathology of myocyte hypertrophy, myofibrillar disarray, fibrosis, and dystrophic calcification. Echocardiography of homozygous mutant mice showed left ventricular dilation and reduced contractile function at birth; myocardial hypertrophy increased as the animals matured. Left-ventricular pressure-volume analyses in adult homozygous mutant mice demonstrated depressed systolic contractility with diastolic dysfunction. These data revise our understanding of the role that MyBP-C plays in myofibrillogenesis during cardiac development and indicate the importance of this protein for long-term sarcomere function and normal cardiac morphology. We also propose that mice bearing homozygous familial hypertrophic cardiomyopathy–causing mutations may provide useful tools for predicting the severity of disease that these mutations will cause in humans.

Authors

Bradley K. McConnell, Karen A. Jones, Diane Fatkin, Luis H. Arroyo, Richard T. Lee, Orlando Aristizabal, Daniel H. Turnbull, Dimitrios Georgakopoulos, David Kass, Meredith Bond, Hideshi Niimura, Frederick J. Schoen, David Conner, Donald H. Fischman, Christine E. Seidman, J.G. Seidman